Immunohistochemical investigation of neuroendocrine component in prostate adenocarcinoma.

Authors

  • O. V. Prokopyk Ukrainian centre pathological anatomy Khmelnitskiy, Ukraine
  • O. G. Kuryk Ukrainian centre pathological anatomy Khmelnitskiy, Ukraine
  • M. D. Andreyev Ukraine National Pirogov Memorial Medical University Vinnica, Ukraine

DOI:

https://doi.org/10.26641/1997-9665.2010.3.39-43

Keywords:

prostate adenocarcinoma, neuroendocrine differentiation, immunohistochemical investigation, chromogranin A, neuron-specific enolase

Abstract

A purpose of current research was to investigate the neuroendocrine component of prostate adenocarcinoma. The immunohistochemical investigation with using markers of neuroendocine differentiation – chromogranin A and neuron-specific enolase was performed. The neuroendocrine differentiation in light-cell adenocarcinoma is more expressive comparing with poorly dark-cell adenocarcinoma, and the neuroendocrine differentiation in moderately differentiated adenocarcinoma is more expressive comparing with poorly differentiated adenocarcinoma.

References

  1. Петров С. В. Руководство по иммуногистиохимической диагностике опухолей человека / под. ред. С. В. Петрова, Н. Т. Райхлина. – Казань : Титул, 2004. – 456 с.
  2. Daneshmand S. Neuroendocrine differentiation in prostate cancer / S. Daneshmand, M. L. Quek, J. Pinski // Cancer Therapy. – 2005. – Vol. 3. – P. 383-396.
  3. Function and molecular mechanisms of neuroendocrsne cells in prostate cancer / J. Huang, C.Wu, P.A. di Sant’Agnese [et al.] // Anal. Quant. Cytol. Histol. – 2007. – Vol. 29. – P. 128-138.
  4. Immunohistochemical characterization of neuroendocrine cеlls in prostate cancer / J. Huang, J. L. Yao, P. A. di Sant’Agnese [et al.] // Prostate. – 2006. – Vol. 66, № 13. – P. 1399-1406.
  5. Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease / A. Berruti, A. Mosca, M. Tucci [et al.] // Endocr. Relat. Cancer. – 2005. – Vol. 12. – P. 109-117.
  6. Neuroendocrine expression in node positive prostate casncer correlation with systemic progression and patient survival / D. G. Bostwick, J. Qian, A. Pacelli [et al.] // J. Urol – 2002. – Vol. 168. – P. 1204-1211.
  7. Sun Y. Neuroendocrine differentiation in prostate cancer / Y. Sun, J. Niu, J. Huang //Am. J. Transl. Res. – 2009. – № 1. – P. 148-162.
  8. Varma M. Diagnostic utility of imunohistochemistry in morphologically difficult prostate cancer: review of literature / M. Varma, B. Jasani // Histopathology. – 2005. – Vol. 47, № 1. – P. 1-16.
  9. Vashchenko N. Neuroendocrine differentiation in prostate cancer implication for a new treatment modalities / N. Vashchenko, P. A. Abrahamsson // Eur. Urol – 2005. – Vol. 47. – P. 147-155.
  10. Wright M. E. Androgen receptor represses the neuroendocrine transdiferentation process in prostate cancer cells / M. E. Wright, M. J. Tsai, R. Aebersold // Mol. Endocrinol. – 2003. – Vol. 17. – P. 1726-37.
  11. Yuan T.-C. Neuroedocrine-like prostate cancer cells: neuroendocrine transdifferentation of prostate adenocarcinoma cells / T. - C. Yuan, S. Veeramini, M. - F. Lin // Endocrine-Related Cancer. – 2007. – Vol. 14, № 3. – P. 531-547.

How to Cite

Prokopyk, O. V., Kuryk, O. G., & Andreyev, M. D. (2010). Immunohistochemical investigation of neuroendocrine component in prostate adenocarcinoma. Морфологія / Morphologia / Morfologìâ, 4(3), 39–43. https://doi.org/10.26641/1997-9665.2010.3.39-43

Issue

Section

Статті